NASDAQ Signals a More Qualitative Gatekeeping Approach to New Listings

On December 19, 2025, U.S. capital markets witnessed a notable regulatory development that reshapes how initial listings are evaluated. Following approval by the U.S. Securities and Exchange Commission, Nasdaq adopted new interpretive guidance, Rule IM-5101-3, that materially broadens its discretion to refuse a company’s initial listing application, even where all numerical listing standards are technically satisfied.

This rule change underscores a clear message from Nasdaq: compliance with minimum financial and distribution thresholds alone no longer guarantees access to the public markets. Instead, Nasdaq is increasingly focused on whether a proposed listing presents broader structural or market-integrity risks, particularly the risk that a company’s securities could be vulnerable to manipulation by third parties after trading begins.

From Rule-Based Review to Risk-Based Judgment

Historically, Nasdaq’s initial listing framework emphasized objective criteria such as market capitalization, public float, shareholder count, and financial performance. While discretionary authority has always existed, it was largely tethered to company-level misconduct or the involvement of individuals with known regulatory histories.

Rule IM-5101-3 reflects a shift away from that narrow focus. Nasdaq has expressly acknowledged that certain recent market disruptions did not stem from issuer wrongdoing, but rather from external trading behavior, including coordinated or promotional trading activity, that distorted price formation shortly after listing. In Nasdaq’s view, these scenarios exposed limitations in a purely rules-driven admission process.

The new rule allows Nasdaq to intervene earlier, before trading begins, when the surrounding facts suggest heightened susceptibility to manipulation, even if no bad acts can be attributed to the issuer itself.

Heightened Scrutiny for Certain Issuers and Deal Structures

Although the rule applies universally, its practical implications are particularly significant for smaller-cap companies, cross-border issuers, and transactions involving less established advisory networks. Nasdaq has indicated that it will consider a broad range of qualitative indicators, assessed collectively rather than in isolation.

Among the considerations Nasdaq may weigh are:

• Geographic and Jurisdictional Exposure
  Nasdaq may examine whether the company’s operational base or controlling persons are located in jurisdictions where regulatory cooperation, shareholder enforcement, or investigative transparency may be limited. Restrictions on data access, legal remedies, or due diligence may factor into this assessment.
• Control Dynamics Beyond Formal Ownership
  The inquiry is not limited to cap tables. Nasdaq may look at informal influence, contractual control rights, or other arrangements that give individuals or entities substantial leverage over company decisions, particularly where those parties are outside U.S. regulatory reach.
• Post-Offering Liquidity Profile
  Even where minimum public float requirements are met, Nasdaq may analyze whether share distribution patterns—based on allocations among underwriters, brokers, or clearing firms—could lead to thin trading, concentrated ownership, or volatility shortly after listing.
• Track Record of Professional Advisors
  One of the most consequential aspects of the rule is its emphasis on third-party advisors. Nasdaq may evaluate whether auditors, underwriters, legal counsel, or other service providers have been associated with prior offerings that experienced unusual trading behavior or regulatory attention.
• Public Company Readiness
  Nasdaq may also consider whether management and directors demonstrate sufficient understanding of U.S. reporting, governance, and compliance obligations, particularly for first-time public company executives.
• Financial Sustainability and Integrity Signals
  Going-concern audit opinions, unresolved regulatory referrals, or other red flags related to governance or disclosure practices may weigh against approval.

Procedural Path Following a Denial

If Nasdaq denies an application under Rule IM-5101-3, it must issue a written determination describing the basis for its decision. The applicant is required to publicly disclose the denial promptly in a Regulation FD-compliant manner. Issuers retain the right to seek review by a Nasdaq Hearings Panel, but the compressed timelines mean that deal momentum and market perception can be materially affected.

Strategic Implications for IPOs and de-SPAC Transactions

This development aligns Nasdaq more closely with other U.S. exchanges that apply rigorous qualitative screening at the entry stage. For issuers, particularly those with Asia-based operations or offshore holding structures, the message is clear: listing risk now extends beyond the issuer’s balance sheet.

Early-stage planning must account for advisor selection, ownership and control transparency, anticipated trading dynamics, and demonstrable readiness for life as a U.S. public company. For sponsors and transaction parties, this also increases the importance of pre-filing diligence and candid assessment of potential listing vulnerabilities.

Our Perspective at Crestfield at Law

Crestfield at Law advises domestic and international clients on IPOs, de-SPAC transactions, uplistings, and ongoing U.S. securities compliance. We regularly assist clients in navigating Nasdaq and SEC expectations, coordinating multi-jurisdictional advisor teams, and addressing qualitative listing risks before they become deal-critical issues.

If you are considering a U.S. listing or are currently in the application process and have questions about how Nasdaq’s expanded discretion may affect your transaction, we welcome the opportunity to discuss strategic and practical considerations with you.

Contact Person: Jan Louise Henry, Esq. and Zhiqi Zheng, Esq.